Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

3.

Could AI plus lasers help catch very early breast cancers?

4.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

5.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot